FDA to Review 20-Valent Pneumococcal Conjugate Vaccine for Pediatric Use
The 20vPnC vaccine consists of capsular polysaccharide conjugates for the 13 serotypes included in Prevnar 13, along with 7 additional serotypes that cause invasive pneumococcal disease.